TABLE 2.
PD-1, CD10, and bcl-6 Immunostaining in Angioimmunoblastic Lymphoma
Case No. | PD-1/CD3* | CD10/CD3* | Bcl-6/CD3* |
---|---|---|---|
1 | 20 | 10 | <5 |
2 | 50 | 25 | <5 |
3 | 50 | 20 | 10 |
4 | 20 | 10 | <5 |
5 | 50 | <5 | <5 |
6 | 50 | 5 | 5 |
7 | 20 | 20 | <5 |
8 | 50 | 50 | 5 |
9 | 20 | 20 | 5 |
10 | 50 | 50 | <5 |
11 | 30 | <5 | <5 |
12 | 20 | 5 | <5 |
13 | 50 | <5 | 5 |
14 | 50 | 25 | 25 |
15 | 20 | 10 | <5 |
16 | 20 | 10 | <5 |
17 | 50 | 25 | <5 |
18 | 50 | 50 | <5 |
19 | 25 | 25 | 10 |
20 | 25 | <5 | ND |
21 | 50 | <5 | 50 |
22 | 50 | 30 | 5 |
23 | 20 | <5 | ND |
Percentage staining of CD3-positive T cells.